載入...

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

BACKGROUND: Limited data is available to guide the choice of the conditioning regimen for patients with acute myeloid leukemia (AML) undergoing transplant with persistent disease. METHODS: We retrospectively compared outcome of fludarabine-treosulfan (FT), thiotepa-busulfan-fludarabine (TBF), and se...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Hematol Oncol
Main Authors: Saraceni, Francesco, Labopin, Myriam, Brecht, Arne, Kröger, Nicolaus, Eder, Matthias, Tischer, Johanna, Labussière-Wallet, Hélène, Einsele, Hermann, Beelen, Dietrich, Bunjes, Donald, Niederwieser, Dietger, Bochtler, Tilmann, Savani, Bipin N., Mohty, Mohamad, Nagler, Arnon
格式: Artigo
語言:Inglês
出版: BioMed Central 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482556/
https://ncbi.nlm.nih.gov/pubmed/31023346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0727-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!